BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 25436812)

  • 61. EGFR mutations and molecularly targeted therapy: a new era in the treatment of lung cancer.
    Dowell JE; Minna JD
    Nat Clin Pract Oncol; 2006 Apr; 3(4):170-1. PubMed ID: 16596125
    [No Abstract]   [Full Text] [Related]  

  • 62. Genetic heterogeneity of the epidermal growth factor receptor in non-small cell lung cancer cell lines revealed by a rapid and sensitive detection system, the peptide nucleic acid-locked nucleic acid PCR clamp.
    Nagai Y; Miyazawa H; Huqun ; Tanaka T; Udagawa K; Kato M; Fukuyama S; Yokote A; Kobayashi K; Kanazawa M; Hagiwara K
    Cancer Res; 2005 Aug; 65(16):7276-82. PubMed ID: 16105816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A Case of Concurrent De Novo C797S and L858R EGFR Mutation Detected in Stage IA Non-Small Cell Lung Cancer Patient.
    Lee JS; Hur JY; Kim HJ; Lee KY; Kim WS
    J Thorac Oncol; 2017 Nov; 12(11):e179-e181. PubMed ID: 29074208
    [No Abstract]   [Full Text] [Related]  

  • 64. Young male with fanconi anemia and EGFR-mutant non-small-cell lung cancer.
    Cathcart-Rake E; Lopez-Chavez A
    J Thorac Oncol; 2014 Nov; 9(11):e83-5. PubMed ID: 25436812
    [No Abstract]   [Full Text] [Related]  

  • 65. Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer?
    Uramoto H; Mitsudomi T
    Br J Cancer; 2007 Mar; 96(6):857-63. PubMed ID: 17325698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non-small cell lung cancer: focus on epidermal growth factor receptor mutation testing and mutation-positive patients.
    Roengvoraphoj M; Tsongalis GJ; Dragnev KH; Rigas JR
    Cancer Treat Rev; 2013 Dec; 39(8):839-50. PubMed ID: 23768755
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Jänne PA; Johnson BE
    Clin Cancer Res; 2006 Jul; 12(14 Pt 2):4416s-4420s. PubMed ID: 16857820
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Consensus for epidermal growth factor receptor gene mutation detection in non-small cell lung cancer].
    Consensus Group for Epidermal Growth Factor Receptor Gene Mutation Detection in Non-Small Cell Lung Cancer
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):700-2. PubMed ID: 22321552
    [No Abstract]   [Full Text] [Related]  

  • 69. Relevance of epidermal growth factor receptor genomic gain in predicting clinical response to kinase inhibitors in non-small-cell lung cancer.
    Reddy GK
    Clin Lung Cancer; 2005 Nov; 7(3):163-5. PubMed ID: 16354309
    [No Abstract]   [Full Text] [Related]  

  • 70. Epidermal growth factor receptor mutations in patients with non-small cell lung cancer.
    Johnson BE; Jänne PA
    Cancer Res; 2005 Sep; 65(17):7525-9. PubMed ID: 16140912
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer.
    Zhang X; Chang A
    J Med Genet; 2007 Mar; 44(3):166-72. PubMed ID: 17158592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. First-generation epidermal growth factor receptor tyrosine kinase inhibitors in EGFR mutation: positive non-small cell lung cancer patients.
    Sequist LV
    J Thorac Oncol; 2008 Jun; 3(6 Suppl 2):S143-5. PubMed ID: 18520299
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutations in the epidermal growth factor receptor gene in non-small cell lung cancer: Impact on treatment beyond gefitinib and erlotinib.
    Heigener DF; Reck M
    Adv Ther; 2011 Feb; 28(2):126-33. PubMed ID: 21181318
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Predicting clinical benefit in non-small-cell lung cancer patients treated with epidermal growth factor tyrosine kinase inhibitors.
    Amler LC; Goddard AD; Hillan KJ
    Cold Spring Harb Symp Quant Biol; 2005; 70():483-8. PubMed ID: 16869787
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Experience on epidermal growth factor receptor gene mutation analysis in non-small cell lung cancer].
    Zhang J; Gao J; Liang ZY; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):712-4. PubMed ID: 22321558
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.